<?xml version="1.0" encoding="US-ASCII"?>
<!--XBRL Document Created with Wdesk from Workiva-->
<!-- -->
<xsd:schema attributeFormDefault="unqualified" elementFormDefault="qualified" targetNamespace="http://www.regeneron.com/20180630" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:nonnum="http://www.xbrl.org/dtr/type/non-numeric" xmlns:num="http://www.xbrl.org/dtr/type/numeric" xmlns:regn="http://www.regeneron.com/20180630" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsd="http://www.w3.org/2001/XMLSchema">
  <xsd:import namespace="http://fasb.org/srt/2018-01-31" schemaLocation="http://xbrl.fasb.org/srt/2018/elts/srt-2018-01-31.xsd" />
  <xsd:import namespace="http://fasb.org/us-gaap/2018-01-31" schemaLocation="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd" />
  <xsd:import namespace="http://fasb.org/us-roles/2018-01-31" schemaLocation="http://xbrl.fasb.org/us-gaap/2018/elts/us-roles-2018-01-31.xsd" />
  <xsd:import namespace="http://fasb.org/us-types/2018-01-31" schemaLocation="http://xbrl.fasb.org/us-gaap/2018/elts/us-types-2018-01-31.xsd" />
  <xsd:import namespace="http://www.xbrl.org/2003/instance" schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd" />
  <xsd:import namespace="http://www.xbrl.org/2003/linkbase" schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" />
  <xsd:import namespace="http://www.xbrl.org/2009/arcrole/fact-explanatoryFact" schemaLocation="http://www.xbrl.org/lrr/arcrole/factExplanatory-2009-12-16.xsd" />
  <xsd:import namespace="http://www.xbrl.org/2009/role/negated" schemaLocation="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd" />
  <xsd:import namespace="http://www.xbrl.org/2009/role/net" schemaLocation="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd" />
  <xsd:import namespace="http://www.xbrl.org/dtr/type/non-numeric" schemaLocation="http://www.xbrl.org/dtr/type/nonNumeric-2009-12-16.xsd" />
  <xsd:import namespace="http://www.xbrl.org/dtr/type/numeric" schemaLocation="http://www.xbrl.org/dtr/type/numeric-2009-12-16.xsd" />
  <xsd:import namespace="http://xbrl.org/2005/xbrldt" schemaLocation="http://www.xbrl.org/2005/xbrldt-2005.xsd" />
  <xsd:import namespace="http://xbrl.sec.gov/country/2017-01-31" schemaLocation="http://xbrl.sec.gov/country/2017/country-2017-01-31.xsd" />
  <xsd:import namespace="http://xbrl.sec.gov/currency/2017-01-31" schemaLocation="http://xbrl.sec.gov/currency/2017/currency-2017-01-31.xsd" />
  <xsd:import namespace="http://xbrl.sec.gov/dei/2018-01-31" schemaLocation="https://xbrl.sec.gov/dei/2018/dei-2018-01-31.xsd" />
  <xsd:import namespace="http://xbrl.sec.gov/exch/2018-01-31" schemaLocation="https://xbrl.sec.gov/exch/2018/exch-2018-01-31.xsd" />
  <xsd:import namespace="http://xbrl.sec.gov/invest/2013-01-31" schemaLocation="http://xbrl.sec.gov/invest/2013/invest-2013-01-31.xsd" />
  <xsd:import namespace="http://xbrl.sec.gov/naics/2017-01-31" schemaLocation="http://xbrl.sec.gov/naics/2017/naics-2017-01-31.xsd" />
  <xsd:import namespace="http://xbrl.sec.gov/sic/2011-01-31" schemaLocation="http://xbrl.sec.gov/sic/2011/sic-2011-01-31.xsd" />
  <xsd:import namespace="http://xbrl.sec.gov/stpr/2018-01-31" schemaLocation="https://xbrl.sec.gov/stpr/2018/stpr-2018-01-31.xsd" />
  <xsd:annotation>
    <xsd:appinfo>
      <link:linkbaseRef xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="regn-20180630_cal.xml" xlink:role="http://www.xbrl.org/2003/role/calculationLinkbaseRef" xlink:type="simple" />
      <link:linkbaseRef xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="regn-20180630_def.xml" xlink:role="http://www.xbrl.org/2003/role/definitionLinkbaseRef" xlink:type="simple" />
      <link:linkbaseRef xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="regn-20180630_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:type="simple" />
      <link:linkbaseRef xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="regn-20180630_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:type="simple" />
      <link:roleType id="CollaborationAgreementsBayerNarrativeDetails" roleURI="http://www.regeneron.com/role/CollaborationAgreementsBayerNarrativeDetails">
        <link:definition>2404410 - Disclosure - Collaboration Agreements Bayer Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CollaborationAgreementsNotes" roleURI="http://www.regeneron.com/role/CollaborationAgreementsNotes">
        <link:definition>2104100 - Disclosure - Collaboration Agreements (Notes)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CollaborationAgreementsSanofiAntibodiesNarrativeDetails" roleURI="http://www.regeneron.com/role/CollaborationAgreementsSanofiAntibodiesNarrativeDetails">
        <link:definition>2404403 - Disclosure - Collaboration Agreements Sanofi - Antibodies Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CollaborationAgreementsSanofiImmunoOncologyNarrativeDetails" roleURI="http://www.regeneron.com/role/CollaborationAgreementsSanofiImmunoOncologyNarrativeDetails">
        <link:definition>2404406 - Disclosure - Collaboration Agreements Sanofi - Immuno-Oncology Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CollaborationAgreementsScheduleOfAccountsReceivableAndDeferredRevenueInformationAntibodyCollaborationDetails" roleURI="http://www.regeneron.com/role/CollaborationAgreementsScheduleOfAccountsReceivableAndDeferredRevenueInformationAntibodyCollaborationDetails">
        <link:definition>2404404 - Disclosure - Collaboration Agreements Schedule of Accounts Receivable and Deferred Revenue Information - Antibody Collaboration (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CollaborationAgreementsScheduleOfAccountsReceivableAndDeferredRevenueInformationBayerCollaborationDetails" roleURI="http://www.regeneron.com/role/CollaborationAgreementsScheduleOfAccountsReceivableAndDeferredRevenueInformationBayerCollaborationDetails">
        <link:definition>2404411 - Disclosure - Collaboration Agreements Schedule of Accounts Receivable and Deferred Revenue Information - Bayer Collaboration (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CollaborationAgreementsScheduleOfAccountsReceivableAndDeferredRevenueInformationIoCollaborationDetails" roleURI="http://www.regeneron.com/role/CollaborationAgreementsScheduleOfAccountsReceivableAndDeferredRevenueInformationIoCollaborationDetails">
        <link:definition>2404407 - Disclosure - Collaboration Agreements Schedule of Accounts Receivable and Deferred Revenue Information - IO Collaboration (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CollaborationAgreementsScheduleOfAccountsReceivableAndDeferredRevenueInformationTevaCollaborationDetails" roleURI="http://www.regeneron.com/role/CollaborationAgreementsScheduleOfAccountsReceivableAndDeferredRevenueInformationTevaCollaborationDetails">
        <link:definition>2404414 - Disclosure - Collaboration Agreements Schedule of Accounts Receivable and Deferred Revenue Information - Teva Collaboration (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CollaborationAgreementsScheduleOfCollaborationRevenueEarnedFromBayerDetails" roleURI="http://www.regeneron.com/role/CollaborationAgreementsScheduleOfCollaborationRevenueEarnedFromBayerDetails">
        <link:definition>2404409 - Disclosure - Collaboration Agreements Schedule of Collaboration Revenue Earned From Bayer (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CollaborationAgreementsScheduleOfCollaborationRevenueEarnedFromSanofiDetails" roleURI="http://www.regeneron.com/role/CollaborationAgreementsScheduleOfCollaborationRevenueEarnedFromSanofiDetails">
        <link:definition>2404402 - Disclosure - Collaboration Agreements Schedule of Collaboration Revenue Earned From Sanofi (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CollaborationAgreementsScheduleOfSignificantChangesInDeferredRevenueBalancesAntibodyCollaborationDetails" roleURI="http://www.regeneron.com/role/CollaborationAgreementsScheduleOfSignificantChangesInDeferredRevenueBalancesAntibodyCollaborationDetails">
        <link:definition>2404405 - Disclosure - Collaboration Agreements Schedule of Significant Changes in Deferred Revenue Balances - Antibody Collaboration (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CollaborationAgreementsScheduleOfSignificantChangesInDeferredRevenueBalancesBayerCollaborationDetails" roleURI="http://www.regeneron.com/role/CollaborationAgreementsScheduleOfSignificantChangesInDeferredRevenueBalancesBayerCollaborationDetails">
        <link:definition>2404412 - Disclosure - Collaboration Agreements Schedule of Significant Changes in Deferred Revenue Balances - Bayer Collaboration (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CollaborationAgreementsScheduleOfSignificantChangesInDeferredRevenueBalancesIoCollaborationDetails" roleURI="http://www.regeneron.com/role/CollaborationAgreementsScheduleOfSignificantChangesInDeferredRevenueBalancesIoCollaborationDetails">
        <link:definition>2404408 - Disclosure - Collaboration Agreements Schedule of Significant Changes in Deferred Revenue Balances - IO Collaboration (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CollaborationAgreementsScheduleOfSignificantChangesInDeferredRevenueBalancesTevaCollaborationDetails" roleURI="http://www.regeneron.com/role/CollaborationAgreementsScheduleOfSignificantChangesInDeferredRevenueBalancesTevaCollaborationDetails">
        <link:definition>2404415 - Disclosure - Collaboration Agreements Schedule of Significant Changes in Deferred Revenue Balances - Teva Collaboration (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CollaborationAgreementsTables" roleURI="http://www.regeneron.com/role/CollaborationAgreementsTables">
        <link:definition>2304301 - Disclosure - Collaboration Agreements (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CollaborationAgreementsTevaNarrativeDetails" roleURI="http://www.regeneron.com/role/CollaborationAgreementsTevaNarrativeDetails">
        <link:definition>2404413 - Disclosure - Collaboration Agreements Teva Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CondensedConsolidatedBalanceSheetUnauditedParenthetical" roleURI="http://www.regeneron.com/role/CondensedConsolidatedBalanceSheetUnauditedParenthetical">
        <link:definition>1001501 - Statement - CONDENSED CONSOLIDATED BALANCE SHEET (Unaudited) (Parenthetical)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CondensedConsolidatedBalanceSheetsUnaudited" roleURI="http://www.regeneron.com/role/CondensedConsolidatedBalanceSheetsUnaudited">
        <link:definition>1001000 - Statement - CONDENSED CONSOLIDATED BALANCE SHEETS (Unaudited)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CondensedConsolidatedStatementsOfCashFlowsUnaudited" roleURI="http://www.regeneron.com/role/CondensedConsolidatedStatementsOfCashFlowsUnaudited">
        <link:definition>1004000 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (Unaudited)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CondensedConsolidatedStatementsOfOperationsAndComprehensiveIncomeUnaudited" roleURI="http://www.regeneron.com/role/CondensedConsolidatedStatementsOfOperationsAndComprehensiveIncomeUnaudited">
        <link:definition>1002000 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE INCOME (Unaudited)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="DerivativeInstrumentsAndHedgingActivitiesNotes" roleURI="http://www.regeneron.com/role/DerivativeInstrumentsAndHedgingActivitiesNotes">
        <link:definition>2124100 - Disclosure - Derivative Instruments and Hedging Activities (Notes)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="DerivativeInstrumentsAndHedgingActivitiesScheduleOfNotionalAmountsOfOutstandingDerivativePositionsDetails" roleURI="http://www.regeneron.com/role/DerivativeInstrumentsAndHedgingActivitiesScheduleOfNotionalAmountsOfOutstandingDerivativePositionsDetails">
        <link:definition>2424402 - Disclosure - Derivative Instruments and Hedging Activities Schedule of Notional Amounts of Outstanding Derivative Positions (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="DerivativeInstrumentsAndHedgingActivitiesTables" roleURI="http://www.regeneron.com/role/DerivativeInstrumentsAndHedgingActivitiesTables">
        <link:definition>2324301 - Disclosure - Derivative Instruments and Hedging Activities (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="DocumentAndEntityInformation" roleURI="http://www.regeneron.com/role/DocumentAndEntityInformation">
        <link:definition>0001000 - Document - Document and Entity Information</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FairValueMeasurementsNarrativeDetails" roleURI="http://www.regeneron.com/role/FairValueMeasurementsNarrativeDetails">
        <link:definition>2409403 - Disclosure - Fair Value Measurements Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FairValueMeasurementsNotes" roleURI="http://www.regeneron.com/role/FairValueMeasurementsNotes">
        <link:definition>2109100 - Disclosure - Fair Value Measurements (Notes)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FairValueMeasurementsScheduleOfAssetsMeasuredAtFairValueOnRecurringBasisDetails" roleURI="http://www.regeneron.com/role/FairValueMeasurementsScheduleOfAssetsMeasuredAtFairValueOnRecurringBasisDetails">
        <link:definition>2409402 - Disclosure - Fair Value Measurements Schedule of Assets Measured at Fair Value on a Recurring Basis (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FairValueMeasurementsTables" roleURI="http://www.regeneron.com/role/FairValueMeasurementsTables">
        <link:definition>2309301 - Disclosure - Fair Value Measurements (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="IncomeTaxesNarrativeDetails" roleURI="http://www.regeneron.com/role/IncomeTaxesNarrativeDetails">
        <link:definition>2426401 - Disclosure - Income Taxes Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="IncomeTaxesNotes" roleURI="http://www.regeneron.com/role/IncomeTaxesNotes">
        <link:definition>2126100 - Disclosure - Income Taxes (Notes)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="InterimFinancialStatementsNarrativeDetails" roleURI="http://www.regeneron.com/role/InterimFinancialStatementsNarrativeDetails">
        <link:definition>2401402 - Disclosure - Interim Financial Statements Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="InterimFinancialStatementsNotes" roleURI="http://www.regeneron.com/role/InterimFinancialStatementsNotes">
        <link:definition>2101100 - Disclosure - Interim Financial Statements (Notes)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="InterimFinancialStatementsScheduleOfBalanceSheetDataDetails" roleURI="http://www.regeneron.com/role/InterimFinancialStatementsScheduleOfBalanceSheetDataDetails">
        <link:definition>2401403 - Disclosure - Interim Financial Statements Schedule of Balance Sheet Data (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="InterimFinancialStatementsScheduleOfStatementsOfOperationsDataDetails" roleURI="http://www.regeneron.com/role/InterimFinancialStatementsScheduleOfStatementsOfOperationsDataDetails">
        <link:definition>2401404 - Disclosure - Interim Financial Statements Schedule of Statements of Operations Data (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="InterimFinancialStatementsTables" roleURI="http://www.regeneron.com/role/InterimFinancialStatementsTables">
        <link:definition>2301301 - Disclosure - Interim Financial Statements (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="InventoriesNotes" roleURI="http://www.regeneron.com/role/InventoriesNotes">
        <link:definition>2112100 - Disclosure - Inventories (Notes)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="InventoriesScheduleOfInventoriesDetails" roleURI="http://www.regeneron.com/role/InventoriesScheduleOfInventoriesDetails">
        <link:definition>2412402 - Disclosure - Inventories Schedule of Inventories (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="InventoriesTables" roleURI="http://www.regeneron.com/role/InventoriesTables">
        <link:definition>2312301 - Disclosure - Inventories (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LegalMattersNarrativeDetails" roleURI="http://www.regeneron.com/role/LegalMattersNarrativeDetails">
        <link:definition>2428401 - Disclosure - Legal Matters Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LegalMattersNotes" roleURI="http://www.regeneron.com/role/LegalMattersNotes">
        <link:definition>2128100 - Disclosure - Legal Matters (Notes)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="MarketableSecuritiesNarrativeDetails" roleURI="http://www.regeneron.com/role/MarketableSecuritiesNarrativeDetails">
        <link:definition>2408405 - Disclosure - Marketable Securities Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="MarketableSecuritiesNotes" roleURI="http://www.regeneron.com/role/MarketableSecuritiesNotes">
        <link:definition>2108100 - Disclosure - Marketable Securities (Notes)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="MarketableSecuritiesScheduleOfDebtSecuritiesBasedOnContractualMaturityDatesDetails" roleURI="http://www.regeneron.com/role/MarketableSecuritiesScheduleOfDebtSecuritiesBasedOnContractualMaturityDatesDetails">
        <link:definition>2408403 - Disclosure - Marketable Securities Schedule of Debt Securities Based on Contractual Maturity Dates (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="MarketableSecuritiesScheduleOfFairValueAndUnrealizedLossesOfDebtSecuritiesDetails" roleURI="http://www.regeneron.com/role/MarketableSecuritiesScheduleOfFairValueAndUnrealizedLossesOfDebtSecuritiesDetails">
        <link:definition>2408404 - Disclosure - Marketable Securities Schedule of Fair Value and Unrealized Losses of Debt Securities (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="MarketableSecuritiesScheduleOfInvestmentsInAvailableForSaleDebtSecuritiesDetails" roleURI="http://www.regeneron.com/role/MarketableSecuritiesScheduleOfInvestmentsInAvailableForSaleDebtSecuritiesDetails">
        <link:definition>2408402 - Disclosure - Marketable Securities Schedule of Investments in Available For Sale Debt Securities (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="MarketableSecuritiesTables" roleURI="http://www.regeneron.com/role/MarketableSecuritiesTables">
        <link:definition>2308301 - Disclosure - Marketable Securities (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="NetIncomePerShareNotes" roleURI="http://www.regeneron.com/role/NetIncomePerShareNotes">
        <link:definition>2107100 - Disclosure - Net Income Per Share (Notes)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="NetIncomePerShareScheduleOfAntidilutiveSecuritiesExcludedFromComputationDetails" roleURI="http://www.regeneron.com/role/NetIncomePerShareScheduleOfAntidilutiveSecuritiesExcludedFromComputationDetails">
        <link:definition>2407403 - Disclosure - Net Income Per Share Schedule of Antidilutive Securities Excluded From Computation (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="NetIncomePerShareScheduleOfBasicAndDilutedNetIncomePerShareDetails" roleURI="http://www.regeneron.com/role/NetIncomePerShareScheduleOfBasicAndDilutedNetIncomePerShareDetails">
        <link:definition>2407402 - Disclosure - Net Income Per Share Schedule of Basic and Diluted Net Income Per Share (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="NetIncomePerShareTables" roleURI="http://www.regeneron.com/role/NetIncomePerShareTables">
        <link:definition>2307301 - Disclosure - Net Income Per Share (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ProductSalesNotes" roleURI="http://www.regeneron.com/role/ProductSalesNotes">
        <link:definition>2103100 - Disclosure - Product Sales (Notes)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ProductSalesScheduleOfConcentrationOfRiskByRiskFactorDetails" roleURI="http://www.regeneron.com/role/ProductSalesScheduleOfConcentrationOfRiskByRiskFactorDetails">
        <link:definition>2403403 - Disclosure - Product Sales Schedule of Concentration of Risk, by Risk Factor (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ProductSalesScheduleOfNetProductSalesDetails" roleURI="http://www.regeneron.com/role/ProductSalesScheduleOfNetProductSalesDetails">
        <link:definition>2403402 - Disclosure - Product Sales Schedule of Net Product Sales (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ProductSalesScheduleOfSalesRelatedDeductionsActivityDetails" roleURI="http://www.regeneron.com/role/ProductSalesScheduleOfSalesRelatedDeductionsActivityDetails">
        <link:definition>2403404 - Disclosure - Product Sales Schedule of Sales Related Deductions Activity (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ProductSalesTables" roleURI="http://www.regeneron.com/role/ProductSalesTables">
        <link:definition>2303301 - Disclosure - Product Sales (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RecentlyIssuedAccountingStandardsNotes" roleURI="http://www.regeneron.com/role/RecentlyIssuedAccountingStandardsNotes">
        <link:definition>2129100 - Disclosure - Recently Issued Accounting Standards (Notes)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RecentlyIssuedAccountingStandardsPolicies" roleURI="http://www.regeneron.com/role/RecentlyIssuedAccountingStandardsPolicies">
        <link:definition>2229201 - Disclosure - Recently Issued Accounting Standards (Policies)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="StatementOfCashFlowsNarrativeDetails" roleURI="http://www.regeneron.com/role/StatementOfCashFlowsNarrativeDetails">
        <link:definition>2427403 - Disclosure - Statement of Cash Flows Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="StatementOfCashFlowsNotes" roleURI="http://www.regeneron.com/role/StatementOfCashFlowsNotes">
        <link:definition>2127100 - Disclosure - Statement of Cash Flows (Notes)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="StatementOfCashFlowsScheduleOfReconciliationOfCashCashEquivalentsAndRestrictedCashDetails" roleURI="http://www.regeneron.com/role/StatementOfCashFlowsScheduleOfReconciliationOfCashCashEquivalentsAndRestrictedCashDetails">
        <link:definition>2427402 - Disclosure - Statement of Cash Flows Schedule of Reconciliation of Cash, Cash Equivalents, and Restricted Cash (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="StatementOfCashFlowsTables" roleURI="http://www.regeneron.com/role/StatementOfCashFlowsTables">
        <link:definition>2327301 - Disclosure - Statement of Cash Flows (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
    </xsd:appinfo>
  </xsd:annotation>
  <xsd:element id="regn_AccruedCapitalExpenditures" name="AccruedCapitalExpenditures" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" xbrli:balance="credit" xbrli:periodType="instant" />
  <xsd:element id="regn_Additionalyearstoextendtheagreement" name="Additionalyearstoextendtheagreement" nillable="true" substitutionGroup="xbrli:item" type="xbrli:durationItemType" xbrli:periodType="duration" />
  <xsd:element id="regn_AggregatefuturedevelopmentmilestonepaymentstheCompanyiseligibletoreceive" name="AggregatefuturedevelopmentmilestonepaymentstheCompanyiseligibletoreceive" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" xbrli:balance="credit" xbrli:periodType="duration" />
  <xsd:element abstract="true" id="regn_Ang2AntibodyMember" name="Ang2AntibodyMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration" />
  <xsd:element id="regn_AnnualFundingMaximumOfResearchActivitiesPerAmendedAgreement" name="AnnualFundingMaximumOfResearchActivitiesPerAmendedAgreement" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" xbrli:balance="debit" xbrli:periodType="duration" />
  <xsd:element abstract="true" id="regn_ArcalystNetProductSalesMember" name="ArcalystNetProductSalesMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration" />
  <xsd:element abstract="true" id="regn_BayerHealthCareLLC.CollaborationAgreementMember" name="BayerHealthCareLLC.CollaborationAgreementMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration" />
  <xsd:element abstract="true" id="regn_BesseMedicalMember" name="BesseMedicalMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration" />
  <xsd:element id="regn_Capitalandfacilityleaseobligationsnoncurrent" name="Capitalandfacilityleaseobligationsnoncurrent" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" xbrli:balance="credit" xbrli:periodType="instant" />
  <xsd:element abstract="true" id="regn_ClassificationOfInvestmentAxis" name="ClassificationOfInvestmentAxis" nillable="true" substitutionGroup="xbrldt:dimensionItem" type="xbrli:stringItemType" xbrli:periodType="duration" />
  <xsd:element abstract="true" id="regn_ClassificationOfInvestmentDomain" name="ClassificationOfInvestmentDomain" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration" />
  <xsd:element abstract="true" id="regn_CollaborationandContractManufacturingMember" name="CollaborationandContractManufacturingMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration" />
  <xsd:element id="regn_CollaborativeArrangementAdditionalEligibleAggregatePayments" name="CollaborativeArrangementAdditionalEligibleAggregatePayments" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" xbrli:balance="debit" xbrli:periodType="duration" />
  <xsd:element abstract="true" id="regn_CurascriptSDMember" name="CurascriptSDMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration" />
  <xsd:element abstract="true" id="regn_DistributionRelatedFeesMember" name="DistributionRelatedFeesMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration" />
  <xsd:element abstract="true" id="regn_DocumentAndEntityInformationAbstract" name="DocumentAndEntityInformationAbstract" nillable="true" substitutionGroup="xbrli:item" type="xbrli:stringItemType" xbrli:periodType="duration" />
  <xsd:element abstract="true" id="regn_EyleaNetProductSalesMember" name="EyleaNetProductSalesMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration" />
  <xsd:element abstract="true" id="regn_GrossSalesRevenueMember" name="GrossSalesRevenueMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration" />
  <xsd:element abstract="true" id="regn_IOAgreementMember" name="IOAgreementMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration" />
  <xsd:element abstract="true" id="regn_IODiscoveryAgreementMember" name="IODiscoveryAgreementMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration" />
  <xsd:element abstract="true" id="regn_IOLicenseandCollaborationAgreementMember" name="IOLicenseandCollaborationAgreementMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration" />
  <xsd:element id="regn_Increaseamountofshareddevelopmentcosts" name="Increaseamountofshareddevelopmentcosts" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" xbrli:balance="debit" xbrli:periodType="instant" />
  <xsd:element id="regn_IncrementalCommonSharesAttributableToNonvestedRestrictedShares" name="IncrementalCommonSharesAttributableToNonvestedRestrictedShares" nillable="true" substitutionGroup="xbrli:item" type="xbrli:sharesItemType" xbrli:periodType="duration" />
  <xsd:element id="regn_Levelsoftwelvemonthsalesatwhichsalesmilestonepaymentswouldbereceived" name="Levelsoftwelvemonthsalesatwhichsalesmilestonepaymentswouldbereceived" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" xbrli:balance="credit" xbrli:periodType="duration" />
  <xsd:element id="regn_Licenseagreementterm" name="Licenseagreementterm" nillable="true" substitutionGroup="xbrli:item" type="xbrli:durationItemType" xbrli:periodType="duration" />
  <xsd:element id="regn_LossContingencyDamagesSoughtperunitproduced." name="LossContingencyDamagesSoughtperunitproduced." nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" xbrli:balance="debit" xbrli:periodType="duration" />
  <xsd:element id="regn_MaximumAmountOfSalesMilestonePaymentsIfTotalSalesAchieveSpecificLevels" name="MaximumAmountOfSalesMilestonePaymentsIfTotalSalesAchieveSpecificLevels" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" xbrli:balance="debit" xbrli:periodType="duration" />
  <xsd:element id="regn_Maximumamountofshareddevelopmentcosts" name="Maximumamountofshareddevelopmentcosts" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" xbrli:balance="debit" xbrli:periodType="instant" />
  <xsd:element id="regn_Maximumsharesthecollaboratorcouldsell" name="Maximumsharesthecollaboratorcouldsell" nillable="true" substitutionGroup="xbrli:item" type="xbrli:sharesItemType" xbrli:periodType="instant" />
  <xsd:element abstract="true" id="regn_McKessonCorporationMember" name="McKessonCorporationMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration" />
  <xsd:element abstract="true" id="regn_NetProfitInConnectionWithCommercializationMember" name="NetProfitInConnectionWithCommercializationMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration" />
  <xsd:element abstract="true" id="regn_OtherCollaborationAgreementsMember" name="OtherCollaborationAgreementsMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration" />
  <xsd:element abstract="true" id="regn_OtherMember" name="OtherMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration" />
  <xsd:element abstract="true" id="regn_OtherSalesRelatedDeductionsMember" name="OtherSalesRelatedDeductionsMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration" />
  <xsd:element abstract="true" id="regn_PD1Member" name="PD1Member" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration" />
  <xsd:element id="regn_PercentageOfTrialCostsBorneByCollaboratingParty" name="PercentageOfTrialCostsBorneByCollaboratingParty" nillable="true" substitutionGroup="xbrli:item" type="num:percentItemType" xbrli:periodType="duration" />
  <xsd:element id="regn_PercentageOfTrialCostsBorneByEntity" name="PercentageOfTrialCostsBorneByEntity" nillable="true" substitutionGroup="xbrli:item" type="num:percentItemType" xbrli:periodType="duration" />
  <xsd:element id="regn_PeriodForAchievingSalesTargetForMilestonePaymentRollingBasis" name="PeriodForAchievingSalesTargetForMilestonePaymentRollingBasis" nillable="true" substitutionGroup="xbrli:item" type="xbrli:durationItemType" xbrli:periodType="duration" />
  <xsd:element abstract="true" id="regn_PraluentKevzaraandDupixentMemberMember" name="PraluentKevzaraandDupixentMemberMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration" />
  <xsd:element id="regn_ProductSalesandConcentrationRiskTextBlock" name="ProductSalesandConcentrationRiskTextBlock" nillable="true" substitutionGroup="xbrli:item" type="nonnum:textBlockItemType" xbrli:periodType="duration" />
  <xsd:element id="regn_ProvisionalchargeforremeasurementofU.S.deferredtaxassetsduetoUSTaxReform" name="ProvisionalchargeforremeasurementofU.S.deferredtaxassetsduetoUSTaxReform" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" xbrli:balance="debit" xbrli:periodType="duration" />
  <xsd:element abstract="true" id="regn_RebatesAndChargebacksMember" name="RebatesAndChargebacksMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration" />
  <xsd:element abstract="true" id="regn_ReimbursementOfCommercializationRelatedExpensesMember" name="ReimbursementOfCommercializationRelatedExpensesMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration" />
  <xsd:element abstract="true" id="regn_ReimbursementOfResearchAndDevelopmentExpensesMember" name="ReimbursementOfResearchAndDevelopmentExpensesMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration" />
  <xsd:element abstract="true" id="regn_ResearchAndDevelopmentArrangementContractToPerformForOthersByProductAxis" name="ResearchAndDevelopmentArrangementContractToPerformForOthersByProductAxis" nillable="true" substitutionGroup="xbrldt:dimensionItem" type="xbrli:stringItemType" xbrli:periodType="duration" />
  <xsd:element abstract="true" id="regn_ResearchAndDevelopmentArrangementContractToPerformForOthersByProductDomain" name="ResearchAndDevelopmentArrangementContractToPerformForOthersByProductDomain" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration" />
  <xsd:element id="regn_RevenuebasedonpercentageofannualsalesinJapan" name="RevenuebasedonpercentageofannualsalesinJapan" nillable="true" substitutionGroup="xbrli:item" type="num:percentItemType" xbrli:periodType="duration" />
  <xsd:element abstract="true" id="regn_SanofiCollaborationAgreementAntibodyMember" name="SanofiCollaborationAgreementAntibodyMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration" />
  <xsd:element abstract="true" id="regn_SanofiCollaborationAgreementImmunooncologyMember" name="SanofiCollaborationAgreementImmunooncologyMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration" />
  <xsd:element abstract="true" id="regn_SanofiCollaborationAgreementMember" name="SanofiCollaborationAgreementMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration" />
  <xsd:element id="regn_ScheduleOfSalesRelatedDeductionsActivityTableTextBlock" name="ScheduleOfSalesRelatedDeductionsActivityTableTextBlock" nillable="true" substitutionGroup="xbrli:item" type="nonnum:textBlockItemType" xbrli:periodType="duration" />
  <xsd:element abstract="true" id="regn_ShareOfLossesInConnectionWithCommercializationMember" name="ShareOfLossesInConnectionWithCommercializationMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration" />
  <xsd:element abstract="true" id="regn_TevaPharmaceuticalsCollaborationAgreementMember" name="TevaPharmaceuticalsCollaborationAgreementMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration" />
  <xsd:element abstract="true" id="regn_UnrestrictedMember" name="UnrestrictedMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration" />
  <xsd:element id="regn_Upfrontpaymentreceived" name="Upfrontpaymentreceived" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" xbrli:balance="credit" xbrli:periodType="duration" />
</xsd:schema>
